Biogen's New Data Highlights SPINRAZA® Benefit in Infants and Toddlers after Gene Therapy

Interim results from the RESPOND study show improved motor function in most participants treated with SPINRAZA after Zolgensma® (onasemnogene abeparv...

July 03, 2023 | Monday | News
Bayer initiates Phase III studies with investigational contrast agent gadoquatrane

Gadoquatrane is a highly stable contrast agent for magnetic resonance imaging (MRI) with high relaxivity and the potential of a substantially lower gadol...

June 28, 2023 | Wednesday | News
Kalos Medical's DENEX Hypertension Treatment System Earns Korean MFDS Innovative Medical Device Designation

The DENEX system is an innovative medical device that treats hypertension using minimally invasive renal denervation technology. Electrodes are inserted in...

June 28, 2023 | Wednesday | News
Medtronic's MiniMed™ 780G System Shows Promising Data on Meal Dosing and Time in Range

These latest data sets, which evaluated the system across a wide range of users, including historically challenging younger patients, those not meeting gly...

June 26, 2023 | Monday | News
Stanford University and Intonation Research Labs Collaborate to Combat Neuroendocrine Tumors

he goal of the collaboration is to reduce the time and resources it takes to translate a biomedical breakthrough into a clinically and commercially viable ...

June 23, 2023 | Friday | News
SciSparc Announces IRB Approval to Conduct its Phase IIb Trial in Tourette Syndrome

SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the developme...

June 22, 2023 | Thursday | News
Diatech Pharmacogenetics Announces New Collaboration to Advance Precision Testing in Oncology

Diatech Pharmacogenetics (“Diatech”) has established a collaboration agreement with Janssen Pharmaceutica NV with the aim of improving access t...

June 21, 2023 | Wednesday | News
FDA Pilot Program Aims to Reduce Risks of Cancer Biomarker Tests

U.S. Food and Drug Administration announced a new voluntary pilot program for certain oncology drug products used with certain corresponding in vitro diagn...

June 21, 2023 | Wednesday | News
FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes

"Compared to adults, children with type 2 diabetes have limited treatment options, even though the disease and symptom onset generally progress more rapidl...

June 21, 2023 | Wednesday | News
QIAGEN's QuantiFERON-TB Gold Plus Shows Unique Clinical Benefits in Tuberculosis Screenings

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) welcomes the publication of a new systematic evaluation that underlines the unique benefits of the compa...

June 16, 2023 | Friday | News
PHC Holdings Acquires SciMed (Asia), Expanding Support for Researchers in Asia-Pacific

SciMed offers life science products and services, including ultra-low temperature freezers and CO2 incubators, in Southeast Asia, India, and Oceania. Since...

June 15, 2023 | Thursday | News
Genomill and iCAN Partner to Enhance Cancer Detection Using Biobank Cohort

Genomill, a pioneering precision diagnostics company, brings its cutting-edge Geno1® platform to the collaboration. Genomill's proprietary and patented...

June 14, 2023 | Wednesday | News
Senju Pharma and Novaliq Sign License Agreement for NOV03 Dry Eye Treatment in Japan

"We are very pleased about the cooperation with Novaliq, a pioneer for groundbreaking non-aqueous eye drop technology. With regard to the unique properties...

June 14, 2023 | Wednesday | News
Neuronetics Receives 510(k) Clearance for OCD MT Cap for NeuroStar Advanced Therapy

Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life fo...

June 13, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close